Cargando…
Association of N(6)-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts
Modification of the novel N(6)-methyladenine (m6A) DNA implicates this epigenetic mark in human malignant disease, but its role in atherosclerosis (AS) is largely unknown. Here, we found that the leukocyte level of m6A but not 5mC DNA modification was decreased with increasing of carotid plaque size...
Autores principales: | Wu, Lianpin, Pei, Yuqing, Zhu, Yinhuan, Jiang, Minghua, Wang, Cheng, Cui, Wei, Zhang, Donghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892866/ https://www.ncbi.nlm.nih.gov/pubmed/31797919 http://dx.doi.org/10.1038/s41419-019-2152-6 |
Ejemplares similares
-
DNA N(6)-methyladenine modification in hypertension
por: Guo, Ye, et al.
Publicado: (2020) -
Changes of N6-methyladenosine modulators promote breast cancer progression
por: Wu, Lianpin, et al.
Publicado: (2019) -
N(6)-Methyladenine Progressively Accumulates in Mitochondrial DNA during Aging
por: Sturm, Ádám, et al.
Publicado: (2023) -
No evidence for DNA N(6)-methyladenine in mammals
por: Douvlataniotis, Karolos, et al.
Publicado: (2020) -
The Key Genes Underlying Pathophysiology Association between Plaque Instability and Progression of Myocardial Infarction
por: Zheng, Yue, et al.
Publicado: (2021)